insights_auto
Why is RXRX down 6.37%?
Dive Deeperchevron_right
RXRX:NASDAQ
Recursion Pharmaceuticals Inc
$2.72
arrow_downward
-6.37%(-0.18) 1D
$2.83
arrow_upward
+4.04% (+0.11)todayPre-market
Closed: Nov 17, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RXRX...
Open
$2.94
High
$2.94
Low
$2.50
Mkt. cap
1.69B
Avg. vol.
26.05M
Volume
52.61K
52-wk high
$5.24
52-wk low
$2.50
EPS
-$0.89
Beta
1.15
Shares outstanding
622.76M
No. of employees
600
Open
$2.94
High
$2.94
Low
$2.50
Mkt. cap
1.69B
Avg. vol.
26.05M
Volume
52.61K
52-wk high
$5.24
52-wk low
$2.50
EPS
-$0.89
Beta
1.15
Shares outstanding
622.76M
No. of employees
600
News stories
From web sources and news partners
Yahoo Finance Singapore
·
5 hours ago
What Recursion Pharmaceuticals Investors Missed Before The Fall
Investing.com
·
16 hours ago
Recursion Pharmaceuticals stock hits 52-week low at 2.76 USD
GuruFocus
·
1 day ago
RXRX Maintains by JP Morgan -- Price Target Lowered to $7.00
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorHealth Care
IndustryBiotechnology
Websiterecursion.com